Endocrinology/Hormones
Endocrinology/hormone inhibitors are compounds that block the action of hormones or interfere with hormone signaling pathways. These inhibitors are essential for studying the regulation of endocrine systems and for developing treatments for hormone-related diseases, such as diabetes, thyroid disorders, and hormone-dependent cancers. By modulating hormone activity, these inhibitors can help elucidate the complex interactions within the endocrine system. At CymitQuimica, we offer a wide range of high-quality endocrinology/hormone inhibitors to support your research in endocrinology, pharmacology, and medical sciences.
Subcategories of "Endocrinology/Hormones"
- Androgen Receptor(229 products)
- Annexin A(16 products)
- Aromatase(23 products)
- Estrogen/progestogen Receptor(66 products)
- GPR(1 products)
- Glucocorticoid Receptor(165 products)
- LHRH(2 products)
- Opioid Receptor(327 products)
- Prostaglandin Receptor(122 products)
- RAAS(89 products)
- Reductase(51 products)
- Somatostatin(57 products)
- Thyroid hormone receptor(THR)(33 products)
- Vasopressin Receptor(48 products)
Show 6 more subcategories
Found 3420 products of "Endocrinology/Hormones"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Androstatrione
CAS:Androstatrione is an androgenic compound.Formula:C19H26O3Color and Shape:SolidMolecular weight:302.41Metahexestrol
CAS:Metahexestrol is an inhibitor of the estrogen receptor (E2R) with antitumor activity. It significantly inhibits the proliferation of estrogen receptor-positive MCF-7 human breast cancer cell line with an ED50 of 1.0 μM. Additionally, Metahexestrol shows inhibitory activity in estrogen receptor-negative MDA-MB-231 cell lines, and its antiproliferative effect is not reversed by estrogen, suggesting that its mechanism may be partially independent of the E2R pathway. Metahexestrol is applicable in research on estrogen-dependent breast cancer.Formula:C18H22O2Color and Shape:SolidMolecular weight:270.366GC 14
CAS:GC 14 is a selective thyroid hormone receptor antagonist, with IC50 values of 200 nM and 35 nM for hTRα and hTRβ, respectively.Formula:C26H27NO6Purity:98%Color and Shape:SolidMolecular weight:449.5LIT-001 free base
CAS:LIT-001, a nonpeptide OT-R agonist, enhances mouse autism-like behavior, with EC50=55 nM and Ki=226 nM.Formula:C28H33N7O2SPurity:98%Color and Shape:SolidMolecular weight:531.67Androgen receptor ligand 1
CAS:Androgen receptorligand 1 is a ligand for the androgen receptor (AR). It interacts with the CRBN E3 ligase via a linker to form an AR-PROTAC degrader. This compound is useful in prostate cancer research.Formula:C19H16F4N2OColor and Shape:SolidMolecular weight:364.34ErSO-DFP
ErSO-DFP activates a-UPR, targets ERα+ cancer cells with high selectivity, and effectively reduces MCF-7 tumours.Formula:C20H17F5N2O2Color and Shape:SolidMolecular weight:412.35Opioid receptor antagonist 1
CAS:Opioid receptor antagonist 1 (Compound 10) is an Orvinol-based antagonist of opioid receptors. It exhibits activity as an antagonist against the analgesic properties of morphine.
Formula:C24H29ClF3NO4Color and Shape:SolidMolecular weight:487.94Galaxolide
CAS:Galaxolide can induce estrogenic activity (Estrogen Receptor/ERR), oxidative stress, and genotoxicity. It also stimulates the enzymatic activities of EROD and GST (Glutathione S-transferase).Formula:C18H26OColor and Shape:SolidMolecular weight:258.40MTI013
MTI013 is a selective inhibitor of SARS-CoV-2 nsp14 Mtase (IC50: 2.98 µM) and an antiviral agent (IC50: 10.33 µM in HCoV-229E infected Huh7 cells). Additionally, MTI013 demonstrates synergistic antiviral effects when used in conjunction with the RdRp inhibitor SHEN26.Formula:C24H26N6O4SColor and Shape:SolidMolecular weight:494.57OT-R agonist 1 TFA
CAS:OT-R agonist 1 TFA (compound 5) is an oxytocin receptor (OT-R) agonist with an EC50 value of 0.39 nM. It exhibits V1A antagonist activity, with an EC50 value of 2432 nM, and can be utilized in studies related to central nervous system diseases.Formula:C37H40F3N7O7SColor and Shape:SolidMolecular weight:783.82CH5447240
CAS:CH5447240: potent hPTHR1 agonist, treats Hypoparathyroidism, EC50 12 nM, 55% oral bioavailability, raises rat serum calcium.Formula:C26H39N5O4SPurity:98%Color and Shape:SolidMolecular weight:517.68ERβ agonist-1
CAS:ERβagonist-1 (Compound 8) functions as a dual-active selective ERβ agonist (EC50: 46.8 nM) and an AR antagonist (IC50: 1555 nM). By binding to ERβ, it activates its signaling pathways while simultaneously inhibiting AR activity. Retaining selective ERβ agonist activity in mouse models, ERβagonist-1 is applicable in prostate cancer research.Formula:C25H36O2Color and Shape:SolidMolecular weight:368.55Emd 52297
CAS:Emd 52297 is an inhibitor of renin.Formula:C39H59N11O7Purity:98%Color and Shape:SolidMolecular weight:793.96ID11916
CAS:ID11916 is an orally active compound functioning as both an androgen receptor (AR) antagonist and a phosphodiesterase 5 (PDE5) inhibitor. It disrupts androgen binding to AR, impedes nuclear translocation, and blocks androgen-dependent transcriptional activity of AR, while simultaneously elevating intracellular cGMP levels by inhibiting PKG activation. Moreover, ID11916 exhibits potent anticancer effects in prostate cancer cell lines VCaP and 22Rv1, as well as in AR-positive breast cancer cell line SK-BR-3.Formula:C29H27F3N8O3SColor and Shape:SolidMolecular weight:624.637AR antagonist 11
CAS:AR antagonist 11 (Compound c2) is a selective androgen receptor antagonist with an IC50 of 0.019 μM. It is also effective against the ARF877L/T878A mutant (IC50: 1.03 μM). Additionally, AR antagonist 11 inhibits LNCaP cell proliferation and decreases PSA protein expression (IC50: 0.54 μM). This compound is applicable in prostate cancer (PCa) research.Formula:C20H17ClN2OColor and Shape:SolidMolecular weight:336.815(E/Z)-OT-R antagonist 1
CAS:(E/Z)-OT-R antagonist 1 is a mixture of the E/Z configurations of OT-R antagonist 1. This compound is a novel, potent, selective, non-peptide OT-R antagonist that inhibits oxytocin-induced intracellular Ca2+ activity with an IC50 of 8 nM.Formula:C28H29N3O4Color and Shape:SolidMolecular weight:471.55Ciprokiren
CAS:Ciprokiren, a renin inhibitor by Roche, halts human renin; IC50: 0.07/0.65 nmol/L. Lowers blood pressure in animals. Preclinical development ceased.Formula:C37H55N5O8SColor and Shape:SolidMolecular weight:729.93Phenethyl 4-ANPP
CAS:Phenethyl 4-ANPP is a MOR (μ-opioid receptor) agonist with a structure similar to known opioids.Formula:C27H32N2Color and Shape:SolidMolecular weight:384.56LEO 134310
CAS:LEO 134310: Selective, non-steroidal GR agonist with 14 nM EC50, for topical skin disease treatment.Formula:C34H40N2O8Color and Shape:SolidMolecular weight:604.69Androgen receptor antagonist 13
CAS:Androgen receptor antagonist 13 (compound 8a) is an orally active androgen receptor antagonist with an IC50 of 0.20 μM. It is used in prostate cancer research.Formula:C16H15N3O3SColor and Shape:SolidMolecular weight:329.37EN1441
CAS:EN1441 is a covalent degrader that targets the androgen receptor (AR) with an EC50 value of 4.2 μM, as well as its truncated variant AR-V7. It selectively and effectively degrades AR and AR-V7 in androgen-independent prostate cancer cells. EN1441 holds potential for research into androgen-independent prostate cancer.Formula:C13H13ClN2O2Color and Shape:SolidMolecular weight:264.708Sob-AM2
CAS:Sob-AM2 is an effective substrate targeting the fatty acid amide hydrolase (FAAH) expressed in the brain, with a Km of 1.3 μM. It delivers higher concentrations of Sobetirome to the central nervous system at minimal peripheral systemic doses, thereby activating the central thyroid hormone receptor β (TRβ).Formula:C21H27NO3Color and Shape:SolidMolecular weight:341.44AKR1C3-IN-5
AKR1C3-IN-5 inhibits AKR1C3, key in prostate/breast cancers, with MCF-7 cell IC50 of 9.6 μM.Formula:C34H44N2O7Color and Shape:SolidMolecular weight:592.72Estrogen receptor antagonist 7
CAS:ER antagonist 7, compound 13, inhibits ERs, halts breast/ovarian cancer cell growth, has anticancer properties.Formula:C23H17N3O4Color and Shape:SolidMolecular weight:399.4AR antagonist 10
CAS:AR antagonist 10 (Compound Y5) is a potent, orally active androgen receptor (AR) antagonist with an IC50 value of 0.04 μM. It demonstrates a dual mechanism of action: antagonizing AR by disrupting AR dimerization and inducing AR degradation through the ubiquitin-proteasome pathway. This compound shows excellent activity against various resistant AR mutants and effectively inhibits the growth of LNCaP xenograft tumors. AR antagonist 10 is applicable for research in resistant prostate cancer.Formula:C18H17ClN4O3SColor and Shape:SolidMolecular weight:404.871PBPE hydrochloride
CAS:PBPE hydrochloride is a derivative of tamoxifen and functions as a selective ligand for antiestrogen binding sites (AEBS). The binding affinity (Ki) of PBPE hydrochloride and MBPE to AEBS is 8.79 nM and 17.57 nM, respectively.Formula:C19H24ClNOColor and Shape:SolidMolecular weight:317.853Estrogen receptor modulator 11
CAS:Estrogen receptor modulator11 (Compound 27) is a tetrahydroisoquinoline derivative. It exhibits affinity for the estrogen receptor (ER), with IC50 values of 285 nM for ERα and 421 nM for ERβ. Estrogen receptor modulator11 does not demonstrate antagonist activity in MCF-7 cell assays.Formula:C21H18FNOColor and Shape:SolidMolecular weight:319.372Bromadoline
CAS:Bromadoline is an opioid compound that exhibits anti-nociceptive properties in rodents.Formula:C15H21BrN2OColor and Shape:SolidMolecular weight:325.244Triisopropyl phosphate
CAS:Triisopropyl phosphate inhibits TFF1 and EGR3 gene expression and exhibits anti-estrogenic activity by suppressing Estradiol-induced proliferation of MCF-7 cells, with an EC50 of 341 μM. Additionally, Triisopropyl phosphate reduces estrogen response element (ERE)-stimulated luciferase activity in MVLN cells, with an EC50 of 900 μM.Formula:C9H21O4PColor and Shape:SolidMolecular weight:224.234LXT34
CAS:LXT34 (Example 2) is a GPR120 agonist with anti-inflammatory properties. This compound enhances GLP-1 formation in the gastrointestinal tract and improves insulin resistance in macrophages and pancreatic cells. LXT34 is applicable in studies related to inflammatory conditions, such as type 2 diabetes, obesity, and non-alcoholic fatty liver disease.Formula:C18H21NO3SColor and Shape:SolidMolecular weight:331.43KNT-127
CAS:KNT-127 is an agonist of δ-Opioid receptor.Formula:C24H24N2O2Purity:98%Color and Shape:SolidMolecular weight:372.46AP5
CAS:AP5: GPR40 agonist, positive allosteric modulator; rat hIP1 EC50: 0.49 nM.Formula:C28H28FNO4Purity:98%Color and Shape:SolidMolecular weight:461.52Naltrindole 5′-isothiocyanate
CAS:Naltrindole 5′-isothiocyanate (5'-NTII) is an irreversible delta opioid receptor antagonist that counters the analgesic effects induced by DSLET without altering the effects caused by DPDPE.Formula:C27H25N3O3SColor and Shape:SolidMolecular weight:471.571Urotensin-II receptor antagonist-1
CAS:Urotensin-II receptor antagonist-1 (compound 1) is a human Urotensin II receptor antagonist with low oral bioavailability (F=0-3% in rats) and a Ki of 16 nM in HEK293 cells expressing human recombinant UT receptors. It inhibits cytochrome P450 enzymes (IC50=0.75 μM for CYP2D6; 1.4 μM for CYP3A4), suppresses κ opioid receptors (EC50=3.2 μM), and targets cardiac sodium channels (Ki=2.5 μM).Formula:C25H31Cl2N3OColor and Shape:SolidMolecular weight:460.439THR-β agonist 4
CAS:THR-β agonist 4 is a potent agonist of THR-β.Formula:C16H11Cl2F2N5O6SColor and Shape:SolidMolecular weight:510.26Androgen receptor antagonist 11
CAS:Androgen receptor antagonist 11 (compound N29) is a selective, orally available antagonist.Formula:C20H19F3N4O3SColor and Shape:SolidMolecular weight:452.45U 80215
CAS:U 80215 is an enzyme-competitive inhibitor.Formula:C42H60N8O6SColor and Shape:SolidMolecular weight:805.04Saprisartan potassium
CAS:Saprisartan potassium is an Angiotensin II Type 1 receptor antagonist and antihypertensive agent.Formula:C25H21BrF3KN4O4SColor and Shape:SolidMolecular weight:649.52Novokinin
CAS:Angiotensin AT2 receptor agonistFormula:C39H61N11O7Purity:98%Color and Shape:SolidMolecular weight:795.9721-Deacetoxy deflazacort
CAS:21-Deacetoxy deflazacort is a dehydrogenated derivative of Deflazacort, which is a glucocorticoid. As an inactive precursor, Deflazacort rapidly converts into the active metabolite, 21-Desacetyldeflazacort. This compound serves as both an anti-inflammatory and immunosuppressive agent.Formula:C23H29NO4Color and Shape:SolidMolecular weight:383.485′-Guanidinonaltrindole
CAS:5′-Guanidinonaltrindole (GNTI) is a selective antagonist of the kappa opioid receptor.Formula:C27H29N5O3Color and Shape:SolidMolecular weight:471.551L162389
CAS:L162389 is an angiotensin II receptor antagonist with a balanced affinity for AT1 and AT2 receptor and stimulates the conversion of phosphatidylinositol.Formula:C31H38N4O4SPurity:99.11% - 99.57%Color and Shape:SolidMolecular weight:562.72BMS-248360
CAS:BMS-248360: Oral dual hAT1/hETA antagonist with Kis of 10nM & 1.9nM, respectively; treats hypertension.Formula:C36H45N5O5SPurity:98%Color and Shape:SolidMolecular weight:659.84GDC-0927 Racemate
CAS:GDC-0927 Racemate is a degrader of estrogen receptor, is used in the research of ER-related diseases, potently inhibits ER-α activity, with an IC50 of 0.2 nM.Formula:C28H28FNO4Purity:98%Color and Shape:SolidMolecular weight:461.52Erα-IN-1
Erα-IN-1 (compound 3c) is an inhibitor of the estrogen receptor α (ERα), effectively blocking ERα activity in MCF7/ERE-LUC cells.Formula:C16H11FN2Color and Shape:SolidMolecular weight:250.27BNTX
CAS:BNTX (7-Benzylidenenaltrexone) is a selective δ1-opioid receptor antagonist. It competitively counteracts the antisecretory effects of DPDPE, Deltorphin 2, and DAMGO. BNTX is applicable in research focused on antinociceptive effects.Formula:C27H27NO4Color and Shape:SolidMolecular weight:429.508OSU-ERb-12
CAS:OSU-ERb-12 is an ERβ agonist that suppresses ovarian cancer cell proliferation both in vitro and in vivo, and decreases the expression of Snail [1] [2].Formula:C15H30B10O2Color and Shape:SolidMolecular weight:350.51GW856464
CAS:GW856464 is an antagonist of MCHR1. It is utilized in research related to cardiovascular diseases and obesity.Formula:C23H20ClN3O3SColor and Shape:SolidMolecular weight:453.94BU72
CAS:BU72 is a potent, long-lasting agonist for μ and κ opioid receptors, with partial agonistic activity at the δ opioid receptor (EC50 values of 0.054, 0.033, and 0.58 nM, respectively). It provides strong, enduring analgesic effects primarily mediated through μ opioid receptors. BU72 also exhibits a prolonged duration of activity and can partially reverse morphine-induced analgesia. It is applicable in studies of opioid dependence.Formula:C28H32N2O2Color and Shape:SolidMolecular weight:428.57GSK866
CAS:GSK866 is a selective glucocorticoid receptor agonist (SEGRA).Formula:C23H21Cl2F4N5O3Color and Shape:SolidMolecular weight:562.34
